
Wayne William Hancock, MB.BS, PhD, FRCPA is internationally recognized for his expertise in cancer immunology and research in cancer therapeutics. He received his medical and research training (MBBS and PHD) at the Monash University, Clayton, Victoria, Australia, and received his F.R.C.P.A. (Pathology), from the Royal College of Pathologists of Australasia.
He has held positions of Professor of Pathology and Laboratory Medicine in the Perelman School of Medicine at the University of Pennsylvania. He provides special expertise in epigenetics and HDAC inhibitors to advise PTX in the development of novel molecules to enhance the new approaches to targeted cancer therapy.